A practical strategy to subcutaneous administered in-situ gelling co-delivery system of arsenic and retinoic acid for the treatment of acute promyelocytic leukemia by Xiao Liu, Weiwei Yin, Andy Samuel Widjaya, Yueying Yang, Yunhu Liu, Yanyan Jiang

Connect to this object online.

PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids by Yanli Wu, Yueying Yang, Wang Wang, Dejuan Sun, Jing Liang, Man Zhu, Hua Li, Lixia Chen

Connect to this object online.

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer by Yang Liu, Wei Xu, Mingxue Li, Yueying Yang, Dejuan Sun, Lidian Chen, Hua Li, Lixia Chen

Connect to this object online.

Application of PROTACs in target identification and validation by Yang Liu, Jing Liang, Rui Zhu, Yueying Yang, Yali Wang, Wenyi Wei, Hua Li, Lixia Chen

Connect to this object online.

Assesment of Adulterated Traditional Chinese Medicines in China: 2003-2017 by Mingzhe Xu, Mingzhe Xu, Baobin Huang, Fang Gao, Chenchen Zhai, Yueying Yang, Lulu Li, Wenya Wang, Luwen Shi, Luwen Shi

Connect to this object online.

CD71-mediated liposomal arsenic-nickel complex combined with all-trans retinoic acid for the efficacy of acute promyelocytic leukemia by Xiao Liu, Lili Zhang, Yueying Yang, Weiwei Yin, Yunhu Liu, Chunyi Luo, Ruizhe Zhang, Zhiguo Long, Yanyan Jiang, Bing Wang

Connect to this object online.

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods by Canrong Wu, Yang Liu, Yueying Yang, Peng Zhang, Wu Zhong, Yali Wang, Qiqi Wang, Yang Xu, Mingxue Li, Xingzhou Li, Mengzhu Zheng, Lixia Chen, Hua Li

Connect to this object online.